Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 152 | $52,053,728 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 516 | 156.54 | 80,775 | D |
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 101 | 154.07 | 15,561 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 9 | 157.3 | 1,416 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 66 | 156.38 | 10,321 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 111 | 155.45 | 17,255 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 142 | 154.54 | 21,945 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 14 | 157.3 | 2,202 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 170 | 155.45 | 26,426 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 100 | 156.38 | 15,638 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 216 | 154.54 | 33,381 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 8 | 158.09 | 1,265 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 84 | 157.3 | 13,213 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 588 | 156.38 | 91,951 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 993 | 155.45 | 154,362 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 1,259 | 154.54 | 194,566 | D |
20 Feb 2024 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 16 Feb 2024 | Sale | 840 | 149.03 | 125,185 | D |
20 Feb 2024 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 16 Feb 2024 | Sale | 3,614 | 148.24 | 535,739 | D |
20 Feb 2024 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 16 Feb 2024 | Sale | 2,576 | 147.5 | 379,960 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 121 | 149.03 | 18,033 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 519 | 148.24 | 76,937 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 369 | 147.5 | 54,428 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 120 | 149.03 | 17,884 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 518 | 148.24 | 76,788 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 369 | 147.5 | 54,428 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 672 | 148.24 | 99,617 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 156 | 149.03 | 23,249 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 480 | 147.5 | 70,800 | D |
05 Feb 2024 16:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2024 | Sale | 269 | 172.38 | 46,370 | D |
05 Feb 2024 16:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2024 | Sale | 820 | 171.14 | 140,335 | D |
05 Feb 2024 16:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2024 | Sale | 502 | 170.01 | 85,345 | D |
29 Dec 2023 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 27 Dec 2023 | Sale | 30,000 | 195 | 5,850,000 | D |
31 May 2024 19:00 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SCHULMAN AMY W | Director | 29 May 2024 | Sale | 63 | 149.76 | 9,435 | D |
31 May 2024 19:00 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SCHULMAN AMY W | Director | 29 May 2024 | Sale | 11,516 | 148.93 | 1,715,078 | D |
31 May 2024 19:00 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SCHULMAN AMY W | Director | 29 May 2024 | Sale | 10,121 | 148.21 | 1,500,033 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 192 | 189.31 | 36,348 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 17 | 188.4 | 3,203 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 101 | 187.37 | 18,924 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 1,107 | 186.39 | 206,334 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 1,869 | 185.54 | 346,774 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 771 | 184.7 | 142,404 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 944 | 186.39 | 175,952 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 1,593 | 185.54 | 295,565 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 658 | 184.7 | 121,533 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 07 Aug 2023 | Sale | 240 | 185.32 | 44,477 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 07 Aug 2023 | Sale | 814 | 184.65 | 150,305 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 07 Aug 2023 | Sale | 3,112 | 183.58 | 571,301 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 945 | 186.39 | 176,139 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 658 | 184.7 | 121,533 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 1,593 | 185.54 | 295,565 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 192 | 189.31 | 36,348 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 17 | 188.4 | 3,203 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 101 | 187.37 | 18,924 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 1,107 | 186.39 | 206,334 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 1,869 | 185.54 | 346,774 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 771 | 184.7 | 142,404 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 450 | 187.71 | 84,470 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 1,389 | 187.04 | 259,799 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 1,714 | 185.99 | 318,787 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 1,535 | 184.89 | 283,806 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 560 | 183.75 | 102,900 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 500 | 182.45 | 91,225 | D |
04 Aug 2023 16:02 | ALNY | ALNYLAM PHARMACEUTICALS Inc | BONNEY MICHAEL W | Director | 03 Aug 2023 | Sale | 300 | 181.08 | 54,324 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 68 | 197.08 | 13,401 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 42 | 195.65 | 8,217 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 414 | 194.94 | 80,705 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 372 | 193.93 | 72,142 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 81 | 193.18 | 15,648 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 93 | 201.3 | 18,721 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 955 | 200.35 | 191,334 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 385 | 199.54 | 76,823 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 715 | 198.03 | 141,591 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 103 | 196.62 | 20,252 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 204 | 195.46 | 39,874 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 129 | 197.08 | 25,423 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 80 | 195.65 | 15,652 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 779 | 194.94 | 151,858 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 700 | 193.93 | 135,751 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 151 | 193.18 | 29,170 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 168 | 197.08 | 33,109 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 104 | 195.65 | 20,348 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 1,013 | 194.94 | 197,474 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 910 | 193.93 | 176,476 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)